Supply problems at the start of the COVID-19 pandemic sparked concerns about fragile pharmaceutical supply chains. Australia must consider how it can drive forward its domestic industry while also being a strong voice for regional cooperation.
Australian Outlook
In this section
Filter in Australian Outlook
Search in Australian Outlook
5014 results